What is Levemir FlexTouch?
Levemir FlexTouch is a type of insulin pen used to administer the drug Levemir, which is a prescription medication used to treat type 1 and type 2 diabetes. The pen contains insulin detemir, a long-acting insulin that helps regulate blood sugar levels in people with diabetes.
The Levemir FlexTouch pen has several features that make it easy and convenient to use. For example, it has a large, clear dosing window that allows users to see the dose they are administering. The pen also has a dial that can be turned to select the desired dose, and a button that can be pressed to inject the insulin.
In addition to these features, the Levemir FlexTouch pen also contains an insulin scale that allows users to see how much insulin is left in the pen. This can be helpful for people who need to monitor their insulin intake closely and ensure that they always have enough medication on hand.
It is important to note that the Levemir FlexTouch pen is not the same as the Levemir FlexPen, which is another type of insulin pen that contains the same medication. However, both pens are manufactured by Novo Nordisk and are designed to provide a similar user experience.
If you have been prescribed Levemir, your healthcare provider can provide guidance on how to use the Levemir FlexTouch pen, including dosing instructions and tips for proper storage and handling of the medication.
Frequently Asked Questions about levemir flextouch
Levemir® is a long-acting insulin that can be taken once or twice daily to control high blood sugar in adults and children with diabetes. Levemir® FlexTouch® will be discontinued as of early February 2023 and replaced by Levemir® FlexPen®, a slightly different type of prefilled pen.
The insulin detemir (rys), or “Levemir®”, in Levemir® FlexPen® is a long-acting insulin used to treat diabetes mellitus. It may be used in combination with oral antidiabetic medicines (diabetes tablets) or as add-on therapy to liraglutide (Victoza®), which is used to treat type 2 diabetes mellitus in adults.
Levemir is a long-acting insulin analogue used as a basal insulin. Levemir is for subcutaneous administration only. Levemir must not be administered intravenously, as it may result in severe hypoglycaemia.
Each milliliter of LEVEMIR contains 100 U (14.2 mg/mL) insulin detemir. Each milliliter of LEVEMIR 10 mL Vial contains the inactive ingredients 65.4 mcg zinc, 2.06 mg m-cresol, 30.0 mg mannitol, 1.80 mg phenol, 0.89 mg disodium phosphate dihydrate, 1.17 mg sodium chloride, and water for injection.
Levemir works by allowing cells throughout the body to uptake glucose (sugar) and convert it into a form that can be used by these cells for energy.
Insulin glargine (Lantus) tends to be absorbed more slowly and for longer than detemir ( Levemir) because it is not as soluble once injected just under the skin. This means it has a longer duration of action and an insignificant peak effect - instead, it delivers consistent blood levels of insulin.
The bottom line
Levemir and Lantus are two long-acting insulins that share many similarities. They're similarly effective and can cause comparable side effects. The biggest difference between them is that Levemir may require twice-daily injections at lower doses. Lantus can typically be injected once a day at any dose.
On June 19, Novo Nordisk announced the launch of its FlexTouch pen for the long-acting basal insulin Levemir (insulin detemir).
When taken once a day, Levemir, a long-acting insulin, is supposed to be taken with your last meal or at bedtime. This serves to provide better blood glucose control while sleeping.
They're similarly effective and can cause comparable side effects. The biggest difference between them is that Levemir may require twice-daily injections at lower doses. Lantus can typically be injected once a day at any dose. Experts don't recommend one insulin over the other.
Insulin detemir, the active ingredient in Levemir, is an insulin analogue with a prolonged duration of action, and is produced by recombinant DNA technology using a genetically modified strain of Saccharomyces cerevisiae.
Levemir is a brand-name prescription medication. It's used to lower blood sugar levels in: adults and children ages 2 years old and older with type 1 diabetes.
When Levemir is taken once daily, inject the insulin with the evening meal or at bedtime. When taken twice daily, the evening dose should be taken with the evening meal, at bedtime, or 12 hours following the morning dose. Prepare your insulin. A rapid- or short-acting insulin is often prescribed with Levemir.
For some people, twice-daily dosing of Levemir may help to manage blood sugar levels better than once-daily dosing. When you first start taking Levemir, your doctor will likely prescribe it once daily. But if your blood sugar level stays too high, your doctor may split your dose into two daily doses instead.
When Levemir is taken once daily, inject the insulin with the evening meal or at bedtime. When taken twice daily, the evening dose should be taken with the evening meal, at bedtime, or 12 hours following the morning dose.
On June 19, Novo Nordisk announced the launch of its FlexTouch pen for the long-acting basal insulin Levemir (insulin detemir).
